Because Animals CEO Shannon Falconer
Courtesy: Because, Animals
The CEO of pet food start-up Because Animals, Shannon Falconer, doesn't eat meat and hasn't for years, but the former Stanford microbiologist and longtime animal rescue volunteer says she never denied her pets the meat they craved. After all, cats are carnivores and dogs are omnivores in the wild.
Falconer and Because Animals co-founder Joshua Errett (also an experienced animal rescuer) have been working to make pet foods that cater to cats' and dogs' "ancestral diet," but do not require slaughtering animals, or raising them in an industrial setting.
This week, the start-up is bringing its Harmless Hunt Cultured Mouse Cat Treats, their first clean meat product, to SuperZoo one of the biggest trade shows in the pet food industry.
The treats are made with mouse tissue grown from stem cells in a food-grade bioreactor on a vegan medium, Falconer explained. No mice were killed to make the treats, but scientists had to take cells from the ears of donor mice to get started. The process involved putting a mouse under a mild anesthetic while their ear was pierced.
Two years later, the donor mice are doing well, Falconer says. Employees of Because Animals adopted all three of them, and they live in a rather plush mouse house.
Joshua Errett, COO and co-founder of Because Animals.
Courtesy: Because, Animals.
Most companies involved in the nascent clean meat industry are focused on producing food for humans.
These include: the Dutch start-up Mosa Meat which garnered buzz with the world's first cultured beef burger in 2013; Israeli venture Aleph Farms, which is making "slaughter-free steaks"; Upside Foods in California, which is making cultured chicken and duck; and Bluu Biosciences developers of cultured seafoods from fish cells, among many others.
As CNBC previously reported, the market for alternative meat -- including clean meat -- is expected to reach $140 billion over the next decade, capturing about 10% of the $1.4 trillion global meat industry.
Clean meat is not without its critics. Nobody has managed to scale lab-grown meat production to levels that show promise for feeding the world quite yet.
Additionally, University of Oxford researchers have noted, "It is not yet clear what the emissions footprints of real cultured production systems will look like." At the same time, animal tech advances promise to make the traditional meat industry healthier, and more sustainable.
Still, venture investors have jumped at the opportunity to disrupt the traditional industry, and hopefully, lessen the negative environmental impacts of global meat consumption. According to a PitchBook analysis, 66 clean meat start-ups have raised $1.77 billion in venture funding from 382 distinct investors already.
For its part, Because Animals has raised $6.7 million to date, from investors including SOSV,Draper Associates and Orkla. SOSV is one of the most active investors in this space, with at least 10 clean meat companies in its portfolio as of July 2021.
A general partner with SOSV, Bill Liao, said Because Animals may cut a faster path to mass production than other clean meat companies.
For one, Because Animals isn't making tiny mouse meat steaks -- it just needs to produce enough cultured mouse tissue to give its pet food a flavor profile cats and dogs will love. (The company's new treats do include other ingredients like cultured yeasts and pumpkin, Falconer told CNBC.)
He added, "One of the biggest challenges in cellular agriculture is sustainable, inexpensive media." Because Animals has developed that very thing and it's vegan.
Many other clean meat ventures have relied on fetal bovine serum, derived from the blood of animals, to help grow and duplicate animal cells for their products. FBS is highly expensive, however, and its use rankles animal rights and climate activists.
Because Animals developed its own animal-free formulation, and Liao believes the technology will be broadly applicable, possibly beyond pet foods.
Falconer, for the time being, says she is focused on the growing pet food category.
The CEO decided to pursue sustainable pet food while she was working as a postdoctoral research fellow at Stanford University's School of Medicine, she recalls.
Microbiologist Shannon Falconer started Because Animals. to bring cellular agriculture to the pet food industry.
Courtesy: Because, Animals.
Research animals were all around her, and she didn't have the expertise to eliminate scientists' need of them. But with her advanced degrees in microbiology and biochemistry, she knew how to cultivate different types of microorganisms and cells in a lab.
Falconer saw the potential to use her scientific skills to reduce or remove animals from the food supply chain. But she also felt that in her own diet, there were many options to choose from both at restaurants and grocery stores. She's mostly a lentils and tofu person, she says, but is a big fan of Impossible Foods' plant-based substitutes for meat products.
"We can always use more," the CEO said, "and I am happy when there are even more alternatives. But there was absolutely nothing for my cats and virtually nothing for dogs."
Falconer initially wondered if pet food was a big enough market to tackle, and how much of an environmental difference it could make to shift meat production for pet food toward cultured ingredients.
Livestock agriculture was responsible for the equivalent of 260.54 metric tons of carbon dioxide emissions in the U.S. in 2019, according to the most recent available EPA data.
The amount of pet food consumed pales in comparison with human meat consumption, Falconer discovered. But pet food is produced from leftovers in the global meat supply chain, including tons of meat that couldn't be sold for human consumption, and meat from fallen animals that die in transit, or from suffocation in farming facilities or from disease.
"All that meat gets shunted into pet food," Falconer said, "And it allows animal agriculture to stay afloat without making any big changes.
Today, the pet food market is growing, buoyed by increased adoption of dogs and cats by millennials, and greater awareness of health benefits through nutrition for pets. According to Grand View Research, the pet food market should grow to around $90.4 billion by 2025.
If Because Animals has the impact Falconer is looking for, a significant portion of that will shift to clean meat and other sustainable products soon. The company's next challenge will be scaling up to a larger commercial kitchen, while continuing to develop new, clean meat pet foods.
See the rest here:
- BioLineRx Announces Positive Results from Pharmacoeconomic Study Positioning Motixafortide as Potential Standard of Care in Stem Cell Mobilization -... - October 17th, 2021
- Misinformation on stem cell treatments for COVID-19 linked to overhyped science, researchers argue - EurekAlert - October 17th, 2021
- FDA Approves Genentech's Tecentriq as Adjuvant Treatment for Certain People With Early Non-Small Cell Lung Cancer - BioSpace - October 17th, 2021
- Nic Chapman: my MS battle and the treatment that's given me hope - The Times - October 17th, 2021
- Dream Body Clinic Stem Cell Therapy Stem Cells HGH - October 13th, 2021
- Hematopoietic Stem Cells - October 13th, 2021
- 3D printing: Healthcare insiders' view on the tech - Verdict - October 13th, 2021
- Top 10 Best Stem Cell Supplement Brands - Healthtrends - October 13th, 2021
- Mitochondrial superoxide dismutase overexpression and low oxygen conditioning hormesis improve the performance of irradiated sterile males |... - October 13th, 2021
- Researchers uncover how cancer cells use sugar residue to evade the immune system - News-Medical.net - October 13th, 2021
- The science and practicality of cultured meat The Stute - The Stute - October 11th, 2021
- Vitro Biopharma Inc. July 31st 2021; 3rd Quarter ended Financial Results of Operations and Shareholder Le - Benzinga - October 11th, 2021
- Want To Support Healthy Bones? It's Time To Get Your Vitamin D In Check - mindbodygreen.com - October 11th, 2021
- Joint : Why Breast Cancer Awareness Matters, and How to Get It Done - marketscreener.com - October 11th, 2021
- Faster healing of wounds can decrease pain and suffering and save lives - KY3 - October 7th, 2021
- Fasting boosts stem cells regenerative capacity | MIT ... - October 7th, 2021
- Adventist Review Online | Vaxed, Vexed, or Other? - Adventist Review - October 7th, 2021
- Sickle cell disease patients given hope for the future with first new treatment in 20 years - iNews - October 7th, 2021
- StemExpress Partners with the Alliance for Regenerative Medicine to Provide COVID-19 Testing for the Cell and Gene Meeting on the Mesa - WCAX - October 7th, 2021
- New Australian-first gene therapy gives Rylee and Saman sight at night and the chance at a new life - ABC News - October 7th, 2021
- Is Stathmin-2 the Next Piece of the ALS Jigsaw Puzzle? - BioSpace - October 7th, 2021
- Ashley Black, Entrepreneur Of The Year For Health And Beauty, To Launch Best-Selling FasciaBlaster System - LatestLY - October 5th, 2021
- 25 Best Body Scrubs and Exfoliators in 2021 - the Trend Spotter - The Trend Spotter - October 5th, 2021
- Potential of exosomes as cell-free therapy | IJN - Dove Medical Press - October 2nd, 2021
- Poseida Therapeutics to Present at Society for Immunotherapy of Cancer 2021 Annual Meeting - PRNewswire - October 2nd, 2021
- 12 of the best face serums 2021 - Medical News Today - October 2nd, 2021
- Humanigen Submits All Planned Modules for Potential Conditional Marketing Authorization from the UK's MHRA - Business Wire - October 2nd, 2021
- Envigo Announces Collaboration With Biocytogen to Distribute the B-NDG Triple Immunodeficient and Humanizable Mouse Model - StreetInsider.com - September 29th, 2021
- Large-Scale Bioproduction of Adherent Cells To Support Advanced Therapy Workflows - Technology Networks - September 29th, 2021
- Sidney author warns against the abuses of technology Saanich News - Saanich News - September 27th, 2021
- Jasper Therapeutics Closes Transaction With Amplitude Healthcare Acquisition Corporation, Creating a Publicly Traded Biotechnology Company Dedicated... - September 25th, 2021
- Dr. Sean Kelishadi provides stem cell therapy for facial procedures - Digital Journal - September 25th, 2021
- Pipeline of cell and gene therapies holds promise for repairing the Parkinsonian brain - EurekAlert - September 25th, 2021
- National Institutes of Health awards Children - EurekAlert - September 25th, 2021
- Amplitude Healthcare Acquisition : Announces Shareholder Approval of Business Combination with Jasper Therapeutics, Inc (Form 8-K) -... - September 25th, 2021
- Can you mix and match COVID vaccines or boosters? What scientists and doctors say - CNET - September 22nd, 2021
- All The Reasons Why You Should Add Nutrient-Dense Mushrooms To Your Diet - NDTV Doctor - September 22nd, 2021
- My children know I have a terminal illness talking openly about cancer benefits all of us - iNews - September 22nd, 2021
- Orthopedic Regenerative Surgical Products Market Size to Expand Significantly by the End of 2031 - BioSpace - September 22nd, 2021
- Health tips from Dr. Oz and Dr. Roizen for 9-21-21 - The Commercial Dispatch - September 22nd, 2021
- Prescription Drugs Can Be Affordable and Innovative - Center For American Progress - September 18th, 2021
- The Promise of Regenerative Medicine to Treat Chronic Pain - Mega Doctor News - September 18th, 2021
- Precise CRISPR gene editing can correct the mutation that causes cystic fibrosis in mini-intestines - Massive Science - September 18th, 2021
- Fate Therapeutics Announces Publication of FT538 Preclinical Data Demonstrating Enhanced ... - The Bakersfield Californian - September 18th, 2021
- A New Company With a Wild Mission: Bring Back the Woolly Mammoth - The New York Times - September 14th, 2021
- TreeFrog Therapeutics Secures $75m In Series B Financing To Advance A Pipeline Of Stem Cell-Derived Cell Therapies And Deploy Proprietary C-Stem... - September 14th, 2021
- Therapeutic inhibition of USP9x-mediated Notch signaling in triple-negative breast cancer - pnas.org - September 14th, 2021
- What are the health benefits of nectarines? - Medical News Today - September 10th, 2021
- Time to humanize European health research with an action plan - POLITICO.eu - September 10th, 2021
- Tiny radio tags reveal the lives of Neotropical stingless bees - Massive Science - September 10th, 2021
- Bristol Myers Squibb Research at ESMO 2021 Demonstrates Clinical Benefits of Immunotherapies in Multiple Hard-to-Treat Advanced or Metastatic Cancers... - September 8th, 2021
- Opdivo: Use with Yervoy, Side Effects, Cost, and More - Healthline - September 8th, 2021
- The Deal in Duluth: Catholics here on their own in seeking a religious exemption to being vaccinated - Duluth News Tribune - September 8th, 2021
- Diagnosis and Treatment of Three Primary Malignant Tumors | BCTT - Dove Medical Press - September 8th, 2021
- Jeff Bezos is reportedly funding Altos Labs, a new anti-ageing venture aiming to cheat death - Screen Shot - September 7th, 2021
- Sorrento Announces Enrollment of First Subject in Brazil Phase 2 Study of COVI-MSC for Treatment of COVID-19 Associated Acute Respiratory Distress in... - September 2nd, 2021
- 11 of the best vitamin C serums 2021 - Medical News Today - September 2nd, 2021
- Joint Committee on Vaccination and Immunisation (JCVI) advice on third primary dose vaccination - GOV.UK - September 2nd, 2021
- Japanese scientists have 3D printed a square of lab-grown wagyu beef - The A.V. Club - September 2nd, 2021
- This Company is Producing Bioprinted Fur, Wool & Eyelashes Which Could Make Fur Farms Obsolete - vegconomist - the vegan business magazine -... - September 2nd, 2021
- Poseida Therapeutics Presents Preliminary Results from Phase 1 Trial of P-PSMA-101 at the 6th Annual CAR- - Benzinga - September 1st, 2021
- Operational Highlights and Financial Results for the Year Ended June 30, 2021 - GlobeNewswire - September 1st, 2021
- KNUCKLES Role in Flower Clock; This Tiny Multi-Functional Protein Helps Complete Floral Development Properly at the Right Time - Science Times - September 1st, 2021
- Outlook on the Multiple Myeloma Drugs Global Market to 2026 - by Therapy, Drug Type, End-user, Distribution Channel and Region - Yahoo Finance - August 30th, 2021
- 6 Benefits of Not Eating Meat (or at Least Less of It) - Healthline - August 30th, 2021
- Cell Therapy Manufacturing Market by Type of Cell Manufactured, Source of Cell, Scale of Operation, Purpose of Manufacturing and Key Geographical... - August 25th, 2021
- The world's first 3D-printed Wagyu beef is revealed-it's marbling like the real thing - Texasnewstoday.com - August 25th, 2021
- Science-Backed Benefits of Prickly Pear Cactus - Healthline - August 25th, 2021
- AdAlta and Carina Biotech to develop next-generation CAR-T cancer therapeutics | More News | News Channels - PipelineReview.com - August 25th, 2021
- Educating California and the world on the benefits of hydrogen-powered transportation - H2 View - August 25th, 2021
- The Future is Fat: The Startups Looking to Fatten up Vegan Food - vegconomist - the vegan business magazine - August 25th, 2021
- This tech investor believes well soon live to 150. Here are his seven longevity hacks - The Irish Times - August 25th, 2021
- The Best New CBD Skincare Products Of 2021 (So Far) - Forbes - August 25th, 2021
- FDA Approval, Efficacy, Boosters and More: Which COVID Vaccine is Best for You? - NBC Chicago - August 25th, 2021
- Plant Stem Cell Market Technology Research and Global Outlook By Our Experts The Manomet Current - The Manomet Current - August 22nd, 2021
- AAPI's National Blood Donation Drive and Stem Cell Registry Launched, Honoring Fallen Covid Warriors The Indian Panorama - The Indian Panorama - August 22nd, 2021
- Stem Cells Facts and Quiz - WebMD - August 20th, 2021
- Stem cells | healthdirect - August 20th, 2021
- Research Study Published in Functional Foods Highlights Benefits of a Proprietary CBD Formula for Neurological Health - The Free Press Tampa - August 20th, 2021
- Leukemia Stem Cell Transplant: Benefits, Procedure, Side ... - August 20th, 2021